in this issue
Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
FDA Seizes Contaminated Heparin from Celsus Laboratories
November 17, 2008 | Deepti Ramesh
U.S. Marshals on the FDA’s request have seized 11 lots of contaminated blood-thinning drug heparin from pharmaceutical manufacturer Celsus Laboratories (Cincinnati), FDA says. The seized drugs include five lots of heparin sodium active pharma ingredients (API) and six lots of heparin lithium, FDA says. The products were found to be contaminated with over-sulfated chondroitin sulfate (OSCS), a substance that mimics heparin’s anticoagulant activity, the agency says. The products were made with raw materials imported from China, it adds. The agency has...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee